Clinical trial Recruiting at 1 site Observational Ages 14 and up Women only

Rapid syphilis testing at family planning visits in Hawai‘i

Official title: Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

Run by Queen's Medical Center · NCT07358949 · Data updated 2026-11-12

This study checks if a quick fingerstick syphilis test done during a family planning visit is practical and acceptable for patients.

More Syphilis Infection trials

Quick facts

Study typeObservational
Ages14 Years and up
SexWomen only
Enrollment70 (estimated)
SponsorQueen's Medical Center
Academic / other
Locations1 site (Honolulu, Hawaii)
StatusRecruiting
StartedJuly 20, 2026
Main results expectedAugust 1, 2027
Study endsDecember 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT07358949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are sexually active adults aged 14+ seeking contraception or abortion services at Queen’s Medical Center who speak English and have capacity for informed consent.

Probably not a fit

Patients who do not want testing or do not meet eligibility criteria may not benefit from rapid testing.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This nonrandomized feasibility study tests the Syphilis Health Check rapid, point-of-care test at a university-affiliated Hawaii family planning clinic. Clinicians will perform the fingerstick test during abortion or contraception visits, with positive results confirmed by laboratory testing. The study aims to see whether offering rapid testing is feasible for staff and acceptable to patients, and to estimate how many participants are needed for future work. Enrollment targets 50–75 sexually active adults ages 14 and older who seek contraception or abortion services in Hawai‘i.

Why it matters

Potential benefit: If successful, patients can learn their syphilis status within the same visit and start treatment promptly if needed.

How similar studies have gone: Previous rapid, point-of-care syphilis tests have shown feasibility in other settings, but this Hawaii study is a focused feasibility assessment in a family planning clinic.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 14 years or older
* Seeking contraception or abortion services
* Sexually active (engages in any form of sexual activity with another person)
* Denies history of syphilis infection
* Can speak and read English
* Displays capacity for informed consent

Exclusion Criteria:

* Confirmed history (by patient report or medical records) of syphilis
* Home address outside Hawai'i
* Currently incarcerated

Number of Subjects:

Recommendations for sample size in pilot studies range from 70 to 100 patients.28 Given this is a nonrandomized feasibility study with no comparator (i.e., to a control or to serological testing), we aim to enroll 50 to 75 participants to support analysis for correlation between variables while being able to achieve relatively small confidence intervals. This number takes into account the practical considerations of study personnel resources and in-person patient volume in our clinic. All patients eligible for the rapid syphilis testing will be approached for study participation.

Where it's running

  • Queen's Medical Center, 1004 Clinic POB1
    Honolulu, Hawaii, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.